Dr. Kudchadkar on the FDA Approval of Avelumab in Merkel Cell Carcinoma

Name: Dr. Kudchadkar on the FDA Approval of Avelumab in Merkel Cell Carcinoma
Uploaded: 2017-03-23T22:30:26.000Z
Description: Ragini Kudchadkar, MD, assistant professor, Department of Hematology and Medical Oncology, associate director, Hematology and Medical Oncology Fellowship Program-Clinical/Service, Emory University School of Medicine, discusses the FDA approval of avelumab for the treatment of patients with Merkel cell carcinoma.

March 23, 2017

Ragini Kudchadkar, MD

Video

In Partnership With:

Ragini Kudchadkar, MD, assistant professor, Department of Hematology and Medical Oncology, associate director, Hematology and Medical Oncology Fellowship Program-Clinical/Service, Emory University School of Medicine, discusses the FDA approval of avelumab for the treatment of patients with Merkel cell carcinoma.